Evidence map›Paper›PMID 27375834›Full record

ReviewOxidative medicine and cellular longevity2016

Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications.

Gabriela Vilema-Enríquez, Aurora Arroyo, Marcelo Grijalva, Ricardo Israel Amador-Zafra, Javier Camacho

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Role of Different Enzymes in HInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. A multimodalFrontiers in toxicology · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Gabriela Vilema-EnríquezDepartamento de Ciencias de la Vida, Universidad de las Fuerzas Armadas (ESPE), Avenida General Rumiñahui, S/N, P.O. Box 171-5-231B, Sangolquí, Ecuador; Centro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas (ESPE), Avenida General Rumiñahui, S/N, P.O. Box 171-5-231B, Sangolquí, Ecuador; Department of Physiology, Anatomy and Genetics, University of Oxford, Le Gros Clark Building, South Parks Road, Oxford OX1 3QX, UK.ORCID 0000-0003-0110-5894
Aurora ArroyoDepartment of Pharmacology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, 07360 Mexico City, DF, Mexico.ORCID 0000-0001-8587-5241
Marcelo GrijalvaDepartamento de Ciencias de la Vida, Universidad de las Fuerzas Armadas (ESPE), Avenida General Rumiñahui, S/N, P.O. Box 171-5-231B, Sangolquí, Ecuador; Centro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas (ESPE), Avenida General Rumiñahui, S/N, P.O. Box 171-5-231B, Sangolquí, Ecuador.ORCID 0000-0003-4970-7202
Ricardo Israel Amador-ZafraDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, 07360 Mexico City, DF, Mexico.ORCID 0000-0002-8414-0638
Javier CamachoDepartamento de Ciencias de la Vida, Universidad de las Fuerzas Armadas (ESPE), Avenida General Rumiñahui, S/N, P.O. Box 171-5-231B, Sangolquí, Ecuador; Department of Pharmacology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, 07360 Mexico City, DF, Mexico.ORCID 0000-0002-8886-086X
Universidad de las Fuerzas Armadas ESPE · ECInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer has a very high mortality-to-incidence ratio, representing one of the main causes of cancer mortality worldwide. Therefore, new treatment strategies are urgently needed. Several diseases including lung cancer have been associated with the action of reactive oxygen species (ROS) from which hydrogen peroxide (H2O2) is one of the most studied. Despite the fact that H2O2 may have opposite effects on cell proliferation depending on the concentration and cell type, it triggers several antiproliferative responses. H2O2 produces both nuclear and mitochondrial DNA lesions, increases the expression of cell adhesion molecules, and increases p53 activity and other transcription factors orchestrating cancer cell death. In addition, H2O2 facilitates the endocytosis of oligonucleotides, affects membrane proteins, induces calcium release, and decreases cancer cell migration and invasion. Furthermore, the MAPK pathway and the expression of genes related to inflammation including interleukins, TNF-α, and NF-κB are also affected by H2O2. Herein, we will summarize the main effects of hydrogen peroxide on human lung cancer leading to suggesting it as a potential therapeutic tool to fight this disease. Because of the multimechanistic nature of this molecule, novel therapeutic approaches for lung cancer based on the use of H2O2 may help to decrease the mortality from this malignancy.

Indexed as

AnimalsCell ProliferationHumansHydrogen PeroxideLung NeoplasmsReactive Oxygen SpeciesHydrogen PeroxideReactive Oxygen Species

Identifiers

PMID27375834
PMCPMC4916325
OpenAlexW2417676241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.